JPMorgan Chase & Co’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.6K | Sell |
2,663
-542
| -17% | -$17K | ﹤0.01% | 4872 |
|
|
2025
Q1 | $95.1K | Sell |
3,205
-443
| -12% | -$13.1K | ﹤0.01% | 4758 |
|
|
2024
Q4 | $108K | Sell |
3,648
-890
| -20% | -$26.3K | ﹤0.01% | 4752 |
|
|
2024
Q3 | $141K | Sell |
4,538
-6,737
| -60% | -$210K | ﹤0.01% | 4598 |
|
|
2024
Q2 | $382K | Buy |
11,275
+3,567
| +46% | +$121K | ﹤0.01% | 3976 |
|
|
2024
Q1 | $501K | Sell |
7,708
-93,374
| -92% | -$6.07M | ﹤0.01% | 3958 |
|
|
2023
Q4 | $6.91M | Buy |
101,082
+36,300
| +56% | +$2.48M | ﹤0.01% | 2360 |
|
|
2023
Q3 | $3.36M | Buy |
64,782
+3,238
| +5% | +$168K | ﹤0.01% | 2670 |
|
|
2023
Q2 | $3.69M | Buy |
61,544
+4,814
| +8% | +$289K | ﹤0.01% | 2685 |
|
|
2023
Q1 | $2.81M | Sell |
56,730
-56,749
| -50% | -$2.81M | ﹤0.01% | 2835 |
|
|
2022
Q4 | $6.48M | Buy |
113,479
+101,271
| +830% | +$5.78M | ﹤0.01% | 2203 |
|
|
2022
Q3 | $573K | Sell |
12,208
-898
| -7% | -$42.1K | ﹤0.01% | 3661 |
|
|
2022
Q2 | $489K | Buy |
+13,106
| New | +$489K | ﹤0.01% | 3896 |
|